Corporate Overview

The Citius family stands in solidarity with the people of Ukraine and condemns the Russian assault on an independent democratic nation.  

The founders of Citius, as well as several members of its Board of Directors and management team, are of Ukrainian descent, with enduring ties to the Ukrainian community.  As the tragic events in Ukraine unfold, the humanitarian crisis grows exponentially. We are reminded that progress, including scientific discovery, is made possible by the ability of free people, living in peace, to exercise the values and rights inherent in democratic societies.  As such, we support the Ukrainian people in their effort to remain a sovereign and democratic nation.

We encourage the entire Citius community to join us in supporting the many individuals and organizations answering the call to provide humanitarian aid to Ukraine. 

Organizations supporting relief efforts in Ukraine

Razom

Revived Soldiers Ukraine

Ukrainian National Women’s League of America

Ukrainian Congress Committee of America

United Ukrainian American Relief Committee

Voices of Children

American Red Cross

Catholic Relief Services

Metrowest Federation United Jewish Appeal Campaign Ukraine Emergency Fund

Unicef

World Central Kitchen

World Union for Progressive Judaism Ukraine Crisis Relief Fund

YMCA

Leonard Mazur, Executive Chairman

Myron Holubiak, President & Chief Executive Officer

Dr. Myron Czuczman, Chief Medical Officer

 

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products.

Read more

Why Invest

5

Diversified Pipeline Candidates

$26.5M

Invested by Founders

$1.8B

Worldwide Sales Potential of Mino-Lok®

2022

Inflection Point for Value Driving Catalysts

Learn more

Latest News

View all news

Latest Presentation

Latest Events

View All Events

Latest Financial Reports

View All Financial Reports